相关实验视频

Updated: Feb 17, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer

Published on: November 2, 2013

前列腺癌高风险生化复发:识别和早期干预策略

Ahmed Hassan Abdelaziz¹, Mai Mohamed Ali Ezz El Din¹, Emad Hamada²

¹Ain Shams University, Cairo, Egypt.

Frontiers in urology

|February 16, 2026

概括

在前列腺癌 (PCa) 中识别高风险的生化复发 (BCR) 是至关重要的. 多学科团队方法和雄激素受体通路抑制剂 (ARPI) 可以优化PCa患者的结果.

科学领域:

在瘤学瘤学.
泌尿器科泌尿器科泌尿器科泌尿器科
临床管理临床管理

背景情况:

前列腺癌 (PCa) 治疗后的生化复发 (BCR) 是潜在的疾病进展信号.
有效识别和管理高风险BCR患者对于改善结果至关重要.

研究的目的:

为识别高风险BCR患者提供专家建议.
探索多学科团队 (MDT) 对PCa管理的影响.
检查雄激素受体信号通路抑制剂 (ARPI) 在优化PCa结果中的作用.

主要方法:

评估当前证据和临床指导方针的风险分层和诊断.
收集和整合来自九名瘤和泌尿病专家的专家意见.
开发一种全面的方法,用于PCa管理中的临床应用.

主要成果:

在标准化识别,风险分层和高风险BCR患者早期管理方面达成协议.
强调MDT方法对个性化PCa治疗计划的好处.
确定ARPI和雄激素剥夺疗法 (ADT) 是关键的治疗考虑因素.

结论:

标准化协议,MDT策略和先进诊断对于改善PCa患者的治疗结果至关重要.
整合ARPI可以提高管理BCR的治疗疗效.
需要进一步的研究来完善预测模型和优化资源配置.

关键词:

埃及埃及埃及埃及受体信号抑制剂受体信号抑制剂生物化学复发的发生.早期检测早期检测这是一个多学科的方法.前列腺癌是前列腺癌.

更多相关视频

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

A New Technique for Treating Low-risk Prostate Cancer—Super Active Surveillance

Published on: November 7, 2025

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...